Discover
LENZ
LENZ Therapeutics, Inc.
3.05
2 x 2.95
22 x 3.55
bid
ask
-
0.44
12.61%
12 @ 06:10 PM
3.09 +0.04 (1.31%)
| Ytd | -80.94% | |
| 1y | -89.99% |
3.04
day range
3.42
3.00
52 week range
32.13
| Open | 3.38 | Prev Close | 3.49 | Low | 3.04 | High | 3.42 | Mkt Cap | 95.83M |
| Vol | 2.26M | Avg Vol | 821.05K | EPS | -4.53 | P/E | N/A | Forward P/E | -13.35 |
| Beta | N/A | Short Ratio | 13.18 | Inst. Own | 99.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-29 | 50-d Avg | 4.10 | 200-d Avg | 8.10 | 1yr Est | 54.25 |
| Income Statement | |||
| Total Revenue | 5.49M | ||
| Revenues (USD) | 5.49M | ||
| Cost of Revenue | 280.00K | ||
| Gross Profit | 5.21M | ||
| Operating Expenses | 39.38M | ||
| Selling, General and Administrative Expense | 39.38M | ||
| Operating Income | -34.17M | ||
| Income Tax Expense | 3.00K | ||
| Net Income | -31.92M | ||
| Net Income Common Stock | -31.92M | ||
| Net Income Common Stock (USD) | -31.92M | ||
| Consolidated Income | -31.92M | ||
| Earnings per Basic Share | -1.02 | ||
| Earnings per Basic Share (USD) | -1.02 | ||
| Earnings per Diluted Share | -1.02 | ||
| Earning Before Interest & Taxes (EBIT) | -31.91M | ||
| Earning Before Interest & Taxes (USD) | -31.91M | ||
| Weighted Average Shares | 31.37M | ||
| Weighted Average Shares Diluted | 31.37M | ||
| Balance Sheet | |||
| Cash and Equivalents | 24.21M | ||
| Cash and Equivalents (USD) | 24.21M | ||
| Investments | 195.80M | ||
| Investments Current | 195.80M | ||
| Trade and Non-Trade Receivables | 442.00K | ||
| Current Assets | 233.28M | ||
| Property, Plant & Equipment Net | 1.52M | ||
| Total Assets | 236.60M | ||
| Total Debt | 122.00K | ||
| Current Liabilities | 17.21M | ||
| Debt Non-Current | 122.00K | ||
| Total Liabilities | 17.33M | ||
| Accumulated Retained Earnings (Deficit) | -300.55M | ||
| Accumulated Other Comprehensive Income | -629.00K | ||
| Shareholders Equity | 219.26M | ||
| Shareholders Equity (USD) | 219.26M | ||
| Assets Non-Current | 3.31M | ||
| Total Debt (USD) | 122.00K | ||
| Deferred Revenue | 785.00K | ||
| Inventory | 4.12M | ||
| Liabilities Non-Current | 122.00K | ||
| Trade and Non-Trade Payables | 6.65M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 110.00K | ||
| Net Cash Flow from Financing | 395.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -564.00K | ||
| Capital Expenditure | -16.00K | ||
| Issuance (Purchase) of Equity Shares | 395.00K | ||
| Net Cash Flow from Investing | 37.75M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 37.77M | ||
| Net Cash Flow from Operations | -38.71M | ||
| Share Based Compensation | 4.47M | ||